Charles River 23rd Annual Biotechnology-Derived Therapeutics Perspectives on Nonclinical Development Symposium

The Charles River 23rd Annual Biotechnology-Derived Therapeutics Perspectives on Nonclinical Development symposium will be held September 11-13, 2017 at Cape Rey Resort, Carlsbad, CA. This three-day symposium with five sessions has a jam-packed agenda with case study presentations from industry leaders from Bluebird, Janssen, Pfizer and Amgen in the nonclinical development of biotherapeutics. Don’t miss out on [...]

July 18th, 2017|

Spotlight: Every Challenge. Every Day. Every Voice.

Behind every patient stands thousands of scientists and researchers working together to develop life-saving treatments. So what happens when a patient meets the people that helped save her life? Watch this 8-minute documentary as Ginger Tam, a lung-cancer patient, meets the researchers who worked on her cancer treatment.  

March 1st, 2017|

Event Recap: Medical Devices Take the Spotlight

By Marie Daghlian; Photos by Eugene Borodin A smart contact lens that monitors blood glucose, video games that promise to enhance cognition, a novel and simple biopsy device that improves patient comfort—these are just a few of the next generation of medical devices showcased at the third annual Rosenman Institute Symposium, held June 22nd at Byers [...]

June 29th, 2016|

2016 Report on Economic Impact of Bay Area Life Science Startups

From the new report from California Life Sciences Institute on the economic strength/aspects of Bay Area life science startups: "OVERVIEW Pre-Series A life science companies in the Bay Area are significantly impacting the local and state economy. This is the key finding of a survey of 137 Bay Area life science startups conducted by the California [...]

June 7th, 2016|

Bridging Kraków and San Francisco

Big3Bio Spotlight: Bridging Kraków and San Francisco Selvita, the largest the largest drug discovery company in Central and Eastern Europe, has just recently opened its West Coast US office in the San Francisco Bay Area. Selvita provides integrated drug discovery services for medium and large biotech and pharmaceutical companies. It has also an early proprietary oncology [...]

March 21st, 2016|

The Big3Bio Event Preview – EPPICon 2016

It all begins with accurate diagnostics. Discovery of accurate biomarkers triggers the development of new therapeutic drugs as well as companion patient side diagnostic tools, and advances and miniaturization in digital health technology are now leading the democratization of diagnostics by placing these critical tools in the form of wearables and cloud-connected home devices in [...]

March 6th, 2016|

The California Life Sciences Industry: A Powerful Economic Engine

California Life Sciences Association (CLSA) and PwC US have released the 2016 California Life Sciences Industry Report, which indicates that California’s life sciences sector had a profound impact on the state’s economy, "showing industry increases in the areas of sector employment growth, wages, research funding and life sciences venture investment." “Our latest report paints a vivid picture of California’s 2,848 [...]

November 13th, 2015|

Part 2 of Q&A with CLSA CEO Sara Radcliffe

Note: Ahead of the BIO Investor Forum in San Francisco, Big3Bio is combining its Q&A series with new California Life Sciences Association (CLSA) President and CEO Sara Radcliffe (part 1 here) with mendelspod. This video feature will run with chapter updates every day of this week. Chapter 1: CLSA - California’s first statewide trade group for biotech   Chapter [...]

October 12th, 2015|

Big3Bio Q&A: CLSA CEO Sara Radcliffe (Part 1)

Note: Ahead of the AdvaMed conference next week in San Diego and the BIO Investor Forum in San Francisco two weeks later, Big3Bio has a two-part Q&A series with new California Life Sciences Association (CLSA) President and CEO Sara Radcliffe – the first part is today through Friday (two questions a day), a week prior to AdvaMed, and the second part [...]

September 28th, 2015|